Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · IEX Real-Time Price · USD
226.78
-0.77 (-0.34%)
At close: Apr 19, 2024, 4:00 PM
227.00
+0.22 (0.10%)
After-hours: Apr 19, 2024, 7:48 PM EDT
CRL Market Cap
CRL has a market cap or net worth of $11.65 billion as of April 19, 2024. Its market cap has increased by 13.37% in one year.
Market Cap
11.65B
Enterprise Value
14.43B
1-Year Change
13.37%
Ranking
Category
Stock Price
$226.78
Market Cap Chart
Since June 23, 2000, CRL's market cap has increased from $226.30M to $11.65B, an increase of 5,045.87%. That is a compound annual growth rate of 17.98%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 18, 2024 | 11.68B | -1.10% |
Apr 17, 2024 | 11.82B | -0.97% |
Apr 16, 2024 | 11.93B | -1.52% |
Apr 15, 2024 | 12.12B | -2.24% |
Apr 12, 2024 | 12.39B | -2.06% |
Apr 11, 2024 | 12.65B | -0.43% |
Apr 10, 2024 | 12.71B | -3.76% |
Apr 9, 2024 | 13.20B | 0.87% |
Apr 8, 2024 | 13.09B | 0.72% |
Apr 5, 2024 | 13.00B | 0.97% |
Apr 4, 2024 | 12.87B | -3.34% |
Apr 3, 2024 | 13.32B | -0.96% |
Apr 2, 2024 | 13.44B | -2.57% |
Apr 1, 2024 | 13.80B | -0.82% |
Mar 28, 2024 | 13.91B | 0.59% |
Mar 27, 2024 | 13.83B | 1.48% |
Mar 26, 2024 | 13.63B | -0.06% |
Mar 25, 2024 | 13.64B | -2.55% |
Mar 22, 2024 | 14.00B | -0.31% |
Mar 21, 2024 | 14.04B | 1.96% |
Mar 20, 2024 | 13.77B | 0.62% |
Mar 19, 2024 | 13.69B | 1.67% |
Mar 18, 2024 | 13.46B | 1.22% |
Mar 15, 2024 | 13.30B | -0.59% |
Mar 14, 2024 | 13.38B | -0.26% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Royalty Pharma | 12.58B |
Revvity | 12.46B |
ShockWave Medical | 12.30B |
Dr. Reddy's Laboratories | 11.85B |
Incyte | 11.75B |
Insulet | 11.64B |
Fresenius Medical Care AG & Co. KGaA | 11.47B |
Medpace Holdings | 11.44B |